El Salvador vs Lower-middle income (World Bank): Hypertension effective treatment coverage (controlled hypertension)
El Salvador
39.4%
in 2019
Lower-middle income (World Bank)
14.3%
in 2019
El Salvador rank
9th
Lower-middle income (World Bank) rank
8th
Hypertension effective treatment coverage (controlled hypertension) over time
- El Salvador
- Lower-middle income (World Bank)
How they compare
El Salvador currently reports 39.4% against 14.3% in Lower-middle income (World Bank), a difference of 25.1%.
That makes El Salvador's figure about 2.8 times Lower-middle income (World Bank)'s.
Across all 30 years both countries report, El Salvador has been ahead every year.
El Salvador ranks 9th and Lower-middle income (World Bank) ranks 8th of 193 countries.
El Salvador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | El Salvador | Lower-middle income (World Bank) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 14.0% | 3.0% | 11.0% | El Salvador |
| 2000s | 23.3% | 6.2% | 17.1% | El Salvador |
| 2010s | 35.5% | 11.5% | 23.9% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), El Salvador or Lower-middle income (World Bank)?
- El Salvador, at 39.4% against 14.3% in Lower-middle income (World Bank) as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between El Salvador and Lower-middle income (World Bank)?
- 25.1%, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Lower-middle income (World Bank)?
- 30 years are reported by both, from 1990 to 2019.
- How do El Salvador and Lower-middle income (World Bank) rank globally for hypertension effective treatment coverage (controlled hypertension)?
- El Salvador ranks 9th and Lower-middle income (World Bank) ranks 8th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.